Branham Law Group, LLP Investigating Chemed Corporation for Possible Fiduciary Breaches
March 15 2012 - 3:01PM
Business Wire
Branham Law Group, LLP announces its
investigation of Chemed Corporation (NYSE:
CHE). This investigation focuses on whether company
executives and administrators breached their fiduciary obligations
by failing to disclose that Chemed engaged in a scheme to
fraudulently bill Medicare for hospice services and failed to
maintain adequate controls in its hospice enrollments and Medicare
billings. It has been reported that a whistleblower complaint has
also been filed alleging similar misconduct.
Concerned shareholders -- or anyone with additional
information about this case -- who would like more information
about their rights and potential remedies can contact
attorney Trey Branham at (855) 722-5910
or
tbranham@branhamlawgroup.com.
The allegations against Chemed include fraudulent Medicare
billings for unqualified hospice care, profiting from unqualified
hospice enrollments, and engaging in a premeditated plan to enroll
unqualified hospice patients and fraudulently bill Medicare.
Moreover, it appears that these actions were a
result of Chemed’s failure to put in place proper internal
controls. Finally, as a result of these actions, it appears that
Chemed’s financial statements were significantly, and materially,
overstated without a reasonable basis.
“These allegations of fraudulent activity and overstated
financials have given rise to great concern about damage to the
company and its shareholders,” said attorney Trey
Branham.
The Branham Law Group, LLP has extensive experience in
securities and commercial litigation and handled claims of investor
fraud, partnership oppression, shareholder derivative suits, and
class actions of all types. The Branham Law Group also advises
whistleblowers on appropriate courses of action.
Chemed (NYSE:CHE)
Historical Stock Chart
From May 2024 to Jun 2024
Chemed (NYSE:CHE)
Historical Stock Chart
From Jun 2023 to Jun 2024